Terapia Ranbaxy Receives EU Manufacturing & Import License

F.A.
Ziarul BURSA #English Section / 26 februarie 2007

Ranbaxy has made important progress in turning Terapia Ranbaxy into a strategic regional center for its European operations by obtaining an EU manufacturing and import license indicating that the leading generic drug producer in Romania complies with EU norms and standards.

The license is of major importance for the company"s ongoing alignment to EU standards as well as with the parent company"s systems. "It is the first and foremost important step in the process of turning our factory in Cluj into a powerful platform for our EU expansion," the company said in a press release.

In June 2006, Ranbaxy Laboratories Ltd. announced the acquisition by Ranbaxy Netherlands BV of 96.7% in the Romanian generic drug producer Terapia SA. Terapia Ranbaxy then became the leading generic drug producer in the country.

Comanda carte

PREŢUL SĂNĂTĂŢII

danescu.ro
arsc.ro
Stiri Locale

Curs valutar BNR

03 Apr. 2025
Euro (EUR)Euro4.9772
Dolar SUA (USD)Dolar SUA4.5116
Franc elveţian (CHF)Franc elveţian5.2235
Liră sterlină (GBP)Liră sterlină5.9419
Gram de aur (XAU)Gram de aur453.3570

convertor valutar

»=
?

mai multe cotaţii valutare

Cotaţii Emitenţi BVB
Cotaţii fonduri mutuale
Teatrul Național I. L. Caragiale Bucuresti
ccib.ro
energyexpo.ro
thediplomat.ro
Studiul 'Imperiul Roman subjugă Împărăţia lui Dumnezeu'
The study 'The Roman Empire subjugates the Kingdom of God'
BURSA
BURSA
Împărăţia lui Dumnezeu pe Pământ
The Kingdom of God on Earth
Carte - Golden calf - the meaning of interest rate
Carte - The crisis solution terminus a quo
www.agerpres.ro
www.dreptonline.ro
www.hipo.ro

adb